BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29485042)

  • 1. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
    Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
    Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.
    Schmitz R; Adam MA; Blazer DG
    World J Surg Oncol; 2019 Nov; 17(1):180. PubMed ID: 31684956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in practice patterns and outcomes: A decade of sarcoma care in the United States.
    Song Y; Ecker BL; Tang R; Maggino L; Roses RE; DeMatteo RP; Fraker DL; Karakousis GC
    Surg Oncol; 2019 Jun; 29():168-177. PubMed ID: 31196484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.
    Abarca T; Gao Y; Monga V; Tanas MR; Milhem MM; Miller BJ
    J Surg Oncol; 2018 Jun; 117(7):1479-1486. PubMed ID: 29633281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
    Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center.
    Eastman BM; Hippe DS; Wootton LS; Nyflot MJ; Thompson MJ; Pollack SM; Kim E; Spraker MB
    BMC Cancer; 2021 May; 21(1):620. PubMed ID: 34039294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
    Bollig CA; Zitsch RP
    Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands.
    Vos M; Blaauwgeers HGT; Ho VKY; van Houdt WJ; van der Hage JA; Been LB; Bonenkamp JJ; Bemelmans MHA; van Dalen T; Haas RL; Grünhagen DJ; Verhoef C;
    Eur J Cancer; 2019 Mar; 110():98-106. PubMed ID: 30776758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis.
    Hallet J; Davis LE; Mahar AL; Liu Y; Zuk V; Gupta V; Earle CC; Coburn NG
    Gastric Cancer; 2020 Mar; 23(2):300-309. PubMed ID: 31628561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
    Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
    Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
    Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.